Home › NDC Lookup › RxCUI directory › RxCUI 312893

Salicylic acid 0.06 MG/MG Topical Gel — RxCUI 312893

RxNorm drug concept · Semantic clinical drug
RxCUI 312893 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312893
Official nameSalicylic acid 0.06 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assalicylic acid 6 % Topical Gel
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)980 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Salicylic Acid Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

🕸️ Concept Web — How Salicylic acid 0.06 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Salicylic acid 0.06 MG/MG Topical Gel RxCUI 312893

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Salicylic acid 9525
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Keralyt 28166
    • Salyntra 2672362
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Salicylic acid Topical Gel 312895
    • Salicylic acid Topical Product 1157604
    • Salicylic acid Topical Gel [Keralyt] 370430
    • Salicylic acid Topical Gel [Salyntra] 2672366
    • Keralyt Topical Product 1170060
    • Salyntra Topical Product 2672364
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Salicylic acid 0.06 MG/MG 340112
    • Salicylic acid 0.06 MG/MG Topical Gel [Keralyt] 212332
    • Salicylic acid 0.06 MG/MG Topical Gel [Salyntra] 2672367
    • Salicylic acid 0.06 MG/MG [Keralyt] 572531
    • Salicylic acid 0.06 MG/MG [Salyntra] 2672363
  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (60000 MG) (salicylic acid 0.06 MG/MG Topical Gel [Keralyt]) / 1 (160 ML) (salicylic acid 60 MG/ML Medicated Shampoo [Keralyt]) } Pack [Keralyt Scalp] 883501
    • {1 (60000 MG) (salicylic acid 0.06 MG/MG Topical Gel) / 1 (160 ML) (salicylic acid 60 MG/ML Medicated Shampoo) } Pack 866892

Showing up to 8 concepts per family — 18 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Salicylic acid 0.06 MG/MG SCDC · 340112
  • Salicylic acid Topical Gel SCDF · 312895
  • Salicylic acid Topical Product SCDG · 1157604
  • {1 (60000 MG) (salicylic acid 0.06 MG/MG Topical Gel) / 1 (160 ML) (salicylic acid 60 MG/ML Medicated Shampoo) } Pack GPCK · 866892

Brand-Name Concepts

  • Salicylic acid 0.06 MG/MG Topical Gel [Keralyt] SBD · 212332
  • Salicylic acid 0.06 MG/MG Topical Gel [Salyntra] SBD · 2672367
  • Salicylic acid 0.06 MG/MG [Keralyt] SBDC · 572531
  • Salicylic acid 0.06 MG/MG [Salyntra] SBDC · 2672363
  • Salicylic acid Topical Gel [Keralyt] SBDF · 370430
  • Salicylic acid Topical Gel [Salyntra] SBDF · 2672366
  • Keralyt Topical Product SBDG · 1170060
  • Salyntra Topical Product SBDG · 2672364
  • Keralyt BN · 28166
  • Salyntra BN · 2672362

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 312893 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
11086-0030-10 100 g in 1 TUBE (11086-030-10) Keralyt Summers Laboratories Inc 2009-11-01
11086-0030-60 60 g in 1 BOTTLE, WITH APPLICATOR (11086-030-60) Keralyt Summers Laboratories Inc 2009-11-01
42192-0134-40 1 TUBE in 1 CARTON (42192-134-40) / 40 g in 1 TUBE Salicylic Acid Acella Pharmaceuticals, LLC 2011-05-19
59088-0261-03 29.57 mL in 1 TUBE (59088-261-03) Salicylic Acid 6% Gel PureTek Corporation 2026-02-19
71085-0073-60 1 BOTTLE, DISPENSING in 1 CARTON (71085-073-60) / 60 g in 1... Salicylic Acid 6% Gel IPG PHARMACEUTICALS, INC. 2025-01-14
Observed labelers: Summers Laboratories Inc (2) · Acella Pharmaceuticals, LLC (1) · IPG PHARMACEUTICALS, INC. (1) · PureTek Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.